Xing Boyuan, Chen Xiangyi, Wang Yalin, Li Shuang, Liang Ying-Kui, Wang Dawei
Department of Ultrasound Imaging, The People's Hospital of China Three Gorges University/the First People's Hospital of Yichang, Yichang, Hubei, China.
Department of Nuclear Medicine, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Front Oncol. 2022 Dec 13;12:1030624. doi: 10.3389/fonc.2022.1030624. eCollection 2022.
S-Detect is a computer-assisted, artificial intelligence-based system of image analysis that has been integrated into the software of ultrasound (US) equipment and has the capacity to independently differentiate between benign and malignant focal breast lesions. Since the revision and upgrade in both the breast imaging-reporting and data system (BI-RADS) US lexicon and the S-Detect software in 2013, evidence that supports improved accuracy and specificity of radiologists' assessment of breast lesions has accumulated. However, such assessment using S-Detect technology to distinguish malignant from breast lesions with a diameter no greater than 2 cm requires further investigation.
The US images of focal breast lesions from 295 patients in our hospital from January 2019 to June 2022 were collected. The BI-RADS data were evaluated by the embedded program and as manually modified prior to the determination of a pathological diagnosis. The receiver operator characteristic (ROC) curves were constructed to compare the diagnostic accuracy between the assessments of the conventional US images, the S-Detect classification, and the combination of the two.
There were 326 lesions identified in 295 patients, of which pathological confirmation demonstrated that 239 were benign and 87 were malignant. The sensitivity, specificity, and accuracy of the conventional imaging group were 75.86%, 93.31%, and 88.65%. The sensitivity, specificity, and accuracy of the S-Detect classification group were 87.36%, 88.28%, and 88.04%, respectively. The assessment of the amended combination of S-Detect with US image analysis (Co-Detect group) was improved with a sensitivity, specificity, and accuracy of 90.80%, 94.56%, and 93.56%, respectively. The diagnostic accuracy of the conventional US group, the S-Detect group, and the Co-Detect group using area under curves was 0.85, 0.88 and 0.93, respectively. The Co-Detect group had a better diagnostic efficiency compared with the conventional US group ( = 3.882, = 0.0001) and the S-Detect group ( = 3.861, = 0.0001). There was no significant difference in distinguishing benign from malignant small breast lesions when comparing conventional US and S-Detect techniques.
The addition of S-Detect technology to conventional US imaging provided a novel and feasible method to differentiate benign from malignant small breast nodules.
S-Detect是一种基于人工智能的计算机辅助图像分析系统,已集成到超声(US)设备软件中,能够独立区分乳腺局灶性病变的良恶性。自2013年乳腺影像报告和数据系统(BI-RADS)超声词典及S-Detect软件修订升级以来,支持提高放射科医生对乳腺病变评估准确性和特异性的证据不断积累。然而,使用S-Detect技术区分直径不超过2 cm的乳腺恶性病变仍需进一步研究。
收集我院2019年1月至2022年6月295例患者乳腺局灶性病变的超声图像。在确定病理诊断前,通过嵌入式程序评估BI-RADS数据并进行手动修改。构建受试者操作特征(ROC)曲线,比较传统超声图像评估、S-Detect分类评估及两者联合评估的诊断准确性。
295例患者共发现326个病变,其中病理证实良性病变239个,恶性病变87个。传统成像组的敏感性、特异性和准确性分别为75.86%、93.31%和88.65%。S-Detect分类组的敏感性、特异性和准确性分别为87.36%、88.28%和88.04%。S-Detect与超声图像分析修正联合评估(联合检测组)的敏感性、特异性和准确性分别提高至90.80%、94.56%和93.56%。传统超声组、S-Detect组和联合检测组的曲线下面积诊断准确性分别为0.85、0.88和0.93。联合检测组与传统超声组(Z = 3.882,P = 0.0001)和S-Detect组(Z = 3.861,P = 0.0001)相比,诊断效率更高。比较传统超声和S-Detect技术时,在区分乳腺小良恶性病变方面无显著差异。
在传统超声成像中添加S-Detect技术为区分乳腺小良恶性结节提供了一种新颖可行的方法。